Insider plans sale of 2,994 TVTX shares

Elizabeth Reed filed a Rule 144 notice to sell 2,994 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/04/2026 on NASDAQ, with an aggregate market value of 96,360.09.

Accepted by SEC EDGAR 02/04/2026 - 04:07 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Elizabeth Reed filed a Rule 144 notice to sell 2,994 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/04/2026 on NASDAQ, with an aggregate market value of 96,360.09.

The filing also lists prior sales during the past three months: 7,175 shares of common stock sold on 02/03/2026 for gross proceeds of 230,463.88, and 10,000 shares sold on 01/20/2026 for gross proceeds of 273,420.00.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing mean for TVTX shareholders?

This Form 144 shows Elizabeth Reed plans to sell 2,994 TVTX common shares under Rule 144. It also discloses two recent sales totaling 17,175 shares, giving investors transparency into her recent trading activity in TVTX stock.

How many TVTX shares is Elizabeth Reed planning to sell under this notice?

The notice states that 2,994 shares of TVTX common stock are to be sold. These shares are to be sold via Morgan Stanley Smith Barney LLC’s Executive Financial Services platform on NASDAQ, with an aggregate market value of 96,360.09.

What recent TVTX stock sales by Elizabeth Reed are disclosed in this Form 144?

The filing lists two recent sales of TVTX common stock: 7,175 shares sold on 02/03/2026 for 230,463.88 and 10,000 shares sold on 01/20/2026 for 273,420.00, providing a three‑month trading history.

At what firm and exchange will Elizabeth Reed’s planned TVTX share sale occur?

The document shows the planned sale of 2,994 TVTX shares will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares are expected to be sold on the NASDAQ stock market on or about 02/04/2026.

How were the 2,994 TVTX shares to be sold by Elizabeth Reed acquired?

According to the filing, the 2,994 TVTX common shares were acquired as restricted stock from the issuer on 01/31/2026. The nature of payment is listed as “Not Applicable,” indicating no separate cash purchase price at acquisition.

What is the purpose of Rule 144 in the context of this TVTX filing?

In this case, Rule 144 provides a framework for Elizabeth Reed to resell restricted TVTX shares. The rule requires disclosure of planned sales, prior three‑month sales, acquisition details, and broker information to promote transparency around insider and affiliate stock sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001283303
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	ELIZABETH REED
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2994	96360.09	89472327	02/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted Stock	Issuer			2994	01/31/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	02/03/2026	7175	230463.88
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	01/20/2026	10000	273420.00

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Elizabeth E. Reed
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)